Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1992-09-08
1993-07-06
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514292, A61K 3155, A61K 3144
Patent
active
052254070
ABSTRACT:
The invention relates to the use of a compound which acts as an antagonist of 5-HT at 5-HT.sub.3 receptors in the treatment of autism or another disorder originating in childhood in which there is mental retardation.
REFERENCES:
patent: 4695578 (1987-09-01), Coates et al.
patent: 4985422 (1991-01-01), North et al.
patent: 5008272 (1991-04-01), Coates et al.
The Merck Manual, 14th edition (1982), MSD Publisher, pp. 1900-1902.
Coates Ian H.
North Peter C.
Oakley Nigel R.
Oxford Alexander W.
Glaxo Group Limited
Henley III Raymond J.
Waddell Frederick E.
LandOfFree
5-HT.sub.3 receptor antagonists for the treatment of autism does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-HT.sub.3 receptor antagonists for the treatment of autism, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-HT.sub.3 receptor antagonists for the treatment of autism will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1689692